Shatavari as an Antifungal Agent

Fungal infections are considered a major public health concern worldwide, not only among immunocompromised patients but also in the general population. Their management is challenging and complicated due to the limited number of antifungal drug classes available and the rapid emergence of resistant strains, which severely compromise treatment outcomes. In addition, many existing antifungal agents are associated with significant toxicity and high treatment costs, further restricting their long-term use. These shortcomings emphasize the need for alternative strategies that are both effective and safe. In recent years, medicinal plants, particularly those long utilized in traditional systems such as Ayurveda, have attracted increasing attention due to the abundance of antifungal bioactive compounds. These bioactives are being explored not only for their direct inhibitory effects on pathogenic fungi but also for their potential to enhance the efficacy of existing antifungal drugs through synergistic interactions. Shatavari is a well-known medicinal plant in Ayurveda that has gained considerable attention from researchers for its numerous pharmacological applications, specifically its antifungal properties. The increasing prevalence of fungal infections, together with the increasing problem of resistance to conventional antifungal drugs, has reinforced the importance of evaluating bioactive phytochemicals from natural origins as alternative antifungal therapies. Therefore, this chapter explores the antifungal properties of Shatavari, emphasizing its key phytochemicals, saponins, flavonoids, and polyphenols, which contribute to its potential bioactivity. The mechanisms of action include disruption of fungal cell wall integrity, inhibition of spore germination, and interference with enzymatic pathways critical for fungal proliferation. Evidence from both in vitro and in vivo studies demonstrates its efficacy against clinically relevant fungal strains such as Candida albicans, Aspergillus niger, and Trichophyton rubrum. The chapter also examines its antifungal spectrum, cellular and molecular modes of action, and potential role as a complementary or alternative therapy in antifungal drug development. Collectively, the findings underscore Shatavari’s promise as a plant-based antifungal remedy with minimal side effects, supporting its future integration into pharmaceutical formulations and encouraging further research and clinical validation.